Pakistan court allows Indian woman to return home

Islamabad, May 24: The Islamabad High Court today allowed an Indian woman, who has sought refuge at the Indian mission here after accusing a Pakistani man of forcibly marrying her, to return to India, a media report said.

Uzma, in her early 20s, had travelled to Pakistan earlier this month. She has said that Pakistani national Tahir Ali "forced" her to marry him at gunpoint.

Justice Mohsin Akhtar Kiyani was hearing pleas filed by Uzma and Ali. While Uzma had requested to be repatriated to India, Ali had asked to be allowed to meet his wife.

The HC assured Uzma, who hails from New Delhi, that she was free to return to India at any point and would be escorted to the Wagah Border with police security, Dawn newspaper reported.

During the hearing, the judge asked Uzma if she wished to speak to her husband but she refused.

She has alleged that her travel documents were stolen by Ali.

Uzma had petitioned the court on May 12 with the request and had submitted a medical report, showing that her daughter was suffering from thalassemia - an inherited blood disorder characterised by abnormal haemoglobin production - and she urgently needed to return to India.

Uzma and Ali reportedly met in Malaysia and fell in love, after which she travelled to Pakistan on May 1 via the Wagah Border. The two contracted nikkah (marriage) on May 3.

Comments

Add new comment

Coastaldigest.com reserves the right to delete or block any comments.
Coastaldigset.com is not responsible for its readers’ comments.
Comments that are abusive, incendiary or irrelevant are strictly prohibited.
Please use a genuine email ID and provide your name to avoid reject.

AstraZeneca to withdraw Covid-19 vaccine globally as demand dips after admitting side effects

News Network

May 8,2024

AstraZeneca said on Tuesday it had initiated the worldwide withdrawal of its COVID-19 vaccine due to a "surplus of available updated vaccines" since the pandemic.

The company also said it would proceed to withdraw the vaccine Vaxzevria's marketing authorizations within Europe.

"As multiple, variant Covid-19 vaccines have since been developed there is a surplus of available updated vaccines," the company said, adding that this had led to a decline in demand for Vaxzevria, which is no longer being manufactured or supplied.

According to media reports, the Anglo-Swedish drugmaker has previously admitted in court documents that the vaccine causes side-effects such as blood clots and low blood platelet counts.

The firm's application to withdraw the vaccine was made on March 5 and came into effect on May 7, according to the Telegraph, which first reported the development.

London-listed AstraZeneca began moving into respiratory syncytial virus vaccines and obesity drugs through several deals last year after a slowdown in growth as COVID-19 medicine sales declined.

Comments